Clinical Trials Directory

Trials / Unknown

UnknownNCT00327314

Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
100 (planned)
Sponsor
Azienda Ospedaliera San Giovanni Battista · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The protocol aims at reducing transplant toxicity and mortality in patients with multiple myeloma.

Detailed description

Primary end points are engraftment and non-relapse mortality. Secondary end points are disease response, overall survival, progression and event free survivals. Patient eligibility criteria. Inclusion criteria included: * Diagnosis of Durie-Salmon stage IIA-IIIB multiple myeloma * Age \> 18 and ≤ 65 years at the start of the donor search * Presence of concurrent co-morbidities precluding myeloablative conditioning or refusal to undergo a conventional allogeneic transplant * Capacity to give informed consent Exclusion criteria included: * Age \> 65 years * Karnofsky performance status score \< 60% * Progressive disease or stable disease for less than three months * Central nervous system (CNS) involvement * Left ventricular ejection fraction \< 35% or symptomatic heart failure * Poorly controlled hypertension * Pulmonary dysfunction with diffusing capacity for carbon monoxide (DLCO) \< 40% and/or need for continuous oxygen supplementation * Abnormal liver disease with a serum bilirubin greater than twice normal or SGOT and/or SGPT greater than four times the upper limits of normal * HIV positive patients * Pregnancy * Refusal to use contraceptive techniques during and for 12 months following treatment Informed consent is obtained during study registration from each patient according to the Institutional Review Boards of the participating centers. The study is conducted according to the Declaration of Helsinki.

Conditions

Interventions

TypeNameDescription
PROCEDURETransplantation
PROCEDUREHematopoietic cell transplantation

Timeline

Start date
2002-12-01
Completion
2006-10-01
First posted
2006-05-18
Last updated
2006-12-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00327314. Inclusion in this directory is not an endorsement.